Top Markets
#1 GEKKO GEKKO +52.86%
#2 ADO Protocol ADO Protocol +38.44%
#3 Pons Pons +31.32%
#4 Helium Helium +31.23%
#5 TENDIES TENDIES +22.79%
#6 龙虾 (Lobster) 龙虾 (Lobster) +20.33%
#7 o1.exchange o1.exchange +19.33%
#8 Giggle Fund Giggle Fund +18.75%
#9 Main Street Yield Main Street Yield +17.48%
#10 Cysic Cysic +15.13%
Coin of the day
GEKKO GEKKO
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Sanofi Consumer Healthcare India Ltd. Sanofi Consumer Healthcare India Ltd.

Sanofi Consumer Healthcare India Ltd.

SANOFICONR
Rangering i aksjer #9184
Sanofi Consumer Healthcare India Limited, an Indian company founded in 2023 and... Sanofi Consumer Healthcare India Limited, an Indian company founded in 2023 and based in Mumbai, specializes in fast-moving consumer healthcare products. The firm's offerings cover categories such as allergy relief, overall well-being, and pain management, featuring prominent brands like Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU. These products are distributed through a comprehensive network that includes distributors, wholesalers, government institutions, hospitals, pharmacies, pharmacy chains, and e-commerce platforms. The company operates as a subsidiary of Opella Healthcare Participations B.V.
Aksjekurs
$46.50
Sist synkronisert: 2026-08-28
Markedsverdi
$1.07B
Endring (1 dag)
1.53%
Endring (1 år)
-20.93%
Land
IN
Handel Sanofi Consumer Healthcare India Ltd. (SANOFICONR)

Kategori

Healthcare
Inntekter for Sanofi Consumer Healthcare India Ltd. (SANOFICONR)
Inntekter i 2026 TTM: 0
Ifølge Sanofi Consumer Healthcare India Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Sanofi Consumer Healthcare India Ltd. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -
US